首页 正文

Comparing eptinezumab with onabotulinumtoxinA in the treatment of chronic migraine: a real-world evidence study

{{output}}
Background: Migraine, a spectrum of episodic headache disorders common in the global population, may evolve into a very debilitating chronic condition, usually underdiagnosed, poorly recognized and difficult to manage. Neurotrans... ...